European guidelines on cardiovascular disease prevention in clinical practice: Past, present, and future: A need for joint forces

Journal of Hypertension

Volumn 26, Issue 2, 2008, Pages 157-160

  Cífková, Renata ^a   Mancia, Giuseppe ^b   Kjeldsen, Sverre E ^c   Laurent, Stephane ^d  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b SAN GERARDO HOSPITAL   (Italy)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL PRACTICE; CORONARY RISK; EDITORIAL; EUROPE; HEALTH SURVEY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; SEX DIFFERENCE; STROKE;

EID: 38149074145     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282f424f9     Document Type: Editorial

References (37)

1. Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernández R, Gray A. European Cardiovascular Statistics: 2005 edition. London: British Heart Foundation; 2005.
2. Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006; 27:1610-1619.
3. Kesteloot H, Sans S, Kromhout D. Evolution of all-cause and cardiovascular mortality in the age-group 75-84 years in Europe in the period 1970-1996. A comparison with worldwide changes. Eur Heart J 2002; 23:384-396.
4. Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J 2006; 27:107-113.
5. Zatonsky W, Willet W. Changes in dietary fat and declining coronary heart mortality in Poland. BMJ 2005; 331:187-188.
6. Pietinen P, Vartiainen E, Seppänen R, Aro A, Puska P. Changes in the diet in Finland from 1972 to 1992: impact on coronary disease risk. Prev Med 1996; 25:243-250.
7. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischemic heart disease in Finland. BMJ 1994; 309:23-27.
8. Truelsen T, Mahönen M, Tolonen H, Asplund K, Bonita R, Vanuzzo D, for the WHO MONICA Project. Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke 2003; 34:1346-1352.
9. Sarti C, Stegmayr B, Tolonen H, Mahonen M, Tuomilehto J, Asplund K, for the WHO MONICA Project. Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA Project. Stroke 2003; 34:1833-1840.
10. Tunstall-Pedoe H, Connaghan J, Woodward M, Tolonen H, Kuulasmaa K. Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid 1990s and the role of medication. BMJ 2006; 332:629-635.
11. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
12. Kastarinen MJ, Antikainen RL, Laatikainen TK, Salomaa VV, Tuomilehto JO, Nissinen AM, et al. Trends in hypertension care in eastern and southwestern Finland during 1982-2002. J Hypertens 2006; 24:829-836.
13. C?́fková R, Škodová Z, Lánská V, Adámková V, Novozámská E, Petržilková Z, et al. Trends in blood pressure levels, prevalence, awareness, treatment and control of hypertension in the Czech population from 1985 to 2000/01. J Hypertens 2004; 22:1479-1485.
14. Redón J, Cea-Calvo L, Lozano JV, Mart?́-Canales JC, Llisteri JL, Aznar J, González-Esteban J, on behalf of the investigators of the PREV-ICTUS Study. Differences in blood pressure control and stroke mortality across Spain. The Prevención de Riesgo de Ictus (PRE-ICTUS) Study. Hypertension 2007; 49:799-805.
15. Cooper RS. Using public health indicators to measure the success of hypertension control. Hypertension 2007; 49:773-774.
16. McKeown T. The role of medicine: dream, mirage, or nemesis? London, England: Nuffield Provincial Hospitals Trust; 1976.
17. Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960-2000. N Engl J Med 2006; 355:920-927.
18. Tunstall-Pedoe H, Kulaasma K, Mahonen M, Tolonen H, Ruokokoski E. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10 year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353:1547-1557.
19. Sans S, Puigdefábregas A, Paluzie G, Balaguer-Vintró I. Increasing trends of acute myocardial infarction in Spain: the MONICA-Catalonia Project. Eur Heart J 2005; 26:505-515.
20. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004; 109:1101-1107.
21. Evans A, Tolonen H, Hense H, Ferrario M, Sans S, Kuulasmaa K. Trends in coronary risk factors in the WHO-MONICA Project. Int J Epidemiol 2001; 30 (Suppl1):S35-40.
22. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al., for the WHO-MONICA Project. Estimating the contribution of changes in classical risk factors to trends in coronary-event rates across the WHO-MONICA project populations. Lancet 2000; 355:675-687.
23. Ford E, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE. Explaining the decrease in US death from coronary disease 1980-2000. N Engl J Med 2007; 356:2388-2398.
24. Reimer W, de Swart E, DeBacquer D, Pyörälä K, Keil U. Smoking behaviour in European patients with established coronary heart disease. Eur Heart J 2006; 27:35-41.
25. Boersma E, Keil U, De Bacquer D, Pyörälä K, Poldermans D, Leprotti C, et al. Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypertens 2003; 21:1831-1840.
26. DeBacquer D, de Backer G, Cokkinos D, Keil U, Montaye M, Ostör E, et al. Overweight and obesity in patients with established cardiovascular disease: are we meeting the challenge? Eur Heart J 2004; 25:121-128.
27. Pyörälä K, Lehto S, De Bacquer D, De Sutter J, Sans S, Keil U, et al., on behalf of the EUROASPIRE I and II group. Risk factor management in diabetic and nondiabetic coronary heart disease patients. Findings from Euroaspire I and II surveys. Diabetologia 2004; 47:1257-1265.
28. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357:995-1001.
29. Pyorala K, de Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and the European Society of Hypertension. Atherosclerosis 1994; 110:121-161.
30. Wood D, de Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19:1434-1503.
31. de Backer G, Ambrosioni E, Bort-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehab 2003; 10 (Suppl 1):S1-S78.
32. Graham I, Atar D, Borch-Jonsen K, Boysen G, Burrell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehab 2007; 14 (Supp 2):S1-S88.
33. Conroy RM, Pyöräla K, Fitzgerald AP, Sans S, Menotti A, de Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE Project. Eur Heart J 2003; 24:987-1003.
34. Mancia G, de Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25:1105-1187.
35. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al., for the Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Guidelines on Diabetes, Prediabetes and Cardiovascular Diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28:88-136.
36. Graham I, Atar D, Borch-Jonsen K, Boysen G, Burrell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehab 2007; 14 (Supp 2):E1-E40.
37. Graham I, Atar D, Borch-Jonsen K, Boysen G, Burrell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2007; 28:2375-2414.